This document is an excerpt from the EUR-Lex website
Document 32006D0286
2006/286/EC: Commission Decision of 12 April 2006 appointing members of the Committee for Orphan Medicinal Products (Text with EEA relevance)
2006/286/EC: Commission Decision of 12 April 2006 appointing members of the Committee for Orphan Medicinal Products (Text with EEA relevance)
2006/286/EC: Commission Decision of 12 April 2006 appointing members of the Committee for Orphan Medicinal Products (Text with EEA relevance)
OJ L 104, 13.4.2006, p. 54–54
(ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, NL, PL, PT, SK, SL, FI, SV)
OJ L 118M, 8.5.2007, p. 606–606
(MT)
No longer in force, Date of end of validity: 16/04/2009
|
13.4.2006 |
EN |
Official Journal of the European Union |
L 104/54 |
COMMISSION DECISION
of 12 April 2006
appointing members of the Committee for Orphan Medicinal Products
(Text with EEA relevance)
(2006/286/EC)
THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Having regard to Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products (1), and in particular Article 4(3) thereof,
Whereas:
|
(1) |
The term of office of the members of the Committee for Orphan Medicinal Products, hereinafter the Committee, set up in accordance with Article 4 of Regulation (EC) No 141/2000 expires on 15 April 2006. It is necessary, therefore, to appoint two new members and to renew the terms of office of certain existing members. |
|
(2) |
The European Medicines Agency has recommended three persons for nomination. |
|
(3) |
The members of the Committee should be appointed for a period of three years starting on 16 April 2006, |
HAS DECIDED AS FOLLOWS:
Article 1
1. The following is hereby appointed member of the Committee for Orphan Medicinal Products, hereinafter referred to as the Committee, to represent patients’ organisations for a term of three years, from 16 April 2006:
|
|
Dr Marie Pauline EVERS. |
2. The following are hereby reappointed members of the Committee to represent patients’ organisations for a term of three years, from 16 April 2006:
|
|
Ms Birthe HOLM; |
|
|
Mr Yann LE CAM. |
Article 2
1. On the recommendation of the European Medicines Agency, the following is hereby appointed member of the Committee for a term of three years, from 16 April 2006:
|
|
Dr Julia DUNNE. |
2. On the recommendation of the European Medicines Agency, the following are hereby reappointed members of the Committee for a term of three years, from 16 April 2006:
|
|
Prof. Gianmartino BENZI; |
|
|
Dr David LYONS. |
Done at Brussels, 12 April 2006.
For the Commission
Günter VERHEUGEN
Vice-President